Sinocare partners Citic unit to bid for Bayer's diabetes business
Hong Kong
SINOCARE INC, a Chinese maker of blood sugar monitors, teamed with an arm of the country's largest brokerage to enter the bidding for Bayer AG's diabetes devices business, people with knowledge of the matter said.
Sinocare made an offer of about US$1 billion with Citic Securities Co's direct investment unit Goldstone Investment Co, the sources said, asking not to be identified as the information is private. It has reached out to …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
France's Casino supermarket chain to axe up to 3,200 jobs
Prada outshines rivals with 16% revenue lift boosted by Miu Miu
Toymaker Hasbro posts quarterly profit beat, slower sales decline
Hilton lifts 2024 profit forecast on international travel demand
China knockoff raid jolts a global throng of fake-fashion influencers
Roche cuts pipeline after research setbacks and sales drop